Patents Assigned to Recopharma AB
  • Publication number: 20140256019
    Abstract: The present invention provides compositions and methods for treating or preventing viral infections.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 11, 2014
    Applicant: RECOPHARMA AB
    Inventor: Jan Holgersson
  • Publication number: 20120165272
    Abstract: The invention features ophthalmic formulations of mucin polypeptides to treat or prevent dry eye.
    Type: Application
    Filed: December 21, 2011
    Publication date: June 28, 2012
    Applicant: Recopharma AB
    Inventors: Jan Holgersson, Anki Nilsson, Nathalie Chatzissavidou, Tomas Johansson
  • Publication number: 20120034220
    Abstract: The present invention provides compositions and methods for augmenting vaccine immunogenicity using mucin-immunoglobulin fusion proteins.
    Type: Application
    Filed: October 11, 2011
    Publication date: February 9, 2012
    Applicant: Recopharma AB
    Inventor: Jan Holgersson
  • Publication number: 20120020969
    Abstract: The present invention provides compositions and methods for treating or preventing viral infections.
    Type: Application
    Filed: September 29, 2011
    Publication date: January 26, 2012
    Applicant: Recopharma AB
    Inventor: Jan Holgersson
  • Patent number: 8034351
    Abstract: The present invention provides compositions and methods for augmenting vaccine immunogenicity using mucin-immunoglobulin fusion proteins.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: October 11, 2011
    Assignee: Recopharma AB
    Inventor: Jan Holgersson
  • Patent number: 7658919
    Abstract: The present invention provides compositions and methods for treating or preventing bacterial infections. Also provide by the invention are genetically modified cell expressing Lewisb carbohydrate epitope.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: February 9, 2010
    Assignee: Recopharma AB
    Inventors: Jan Holgersson, Jining Liu, Anki Gustafsson, Jonas Lofling
  • Patent number: 7638323
    Abstract: The present invention provides compositions and methods for treating or preventing hyperacute rejection.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: December 29, 2009
    Assignee: Recopharma AB
    Inventors: Jan Holgersson, Jining Liu, Anki Gustafsson
  • Publication number: 20090286963
    Abstract: The present invention relates to an antigenic fusionprotein, which carries multiple Gal?1,3Gal epitopes. The fusion protein according to the invention may also be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1, and a part, which exhibits immunoglobulin properties, such as the Fc part of IgG. The fusionprotein according to the invention is preferably used as an absorber to prevent a hyperacute rejection of a xenotransplant, such as a pig tissue or organ transplanted into a human patient. In addition, the invention relates to a method for the prevention of a hyperacute rejection reaction in a patient who is to receive a xenotransplant.
    Type: Application
    Filed: July 22, 2009
    Publication date: November 19, 2009
    Applicant: Recopharma AB
    Inventors: Jan Holgersson, Jining Liu
  • Publication number: 20090280134
    Abstract: The present invention provides compositions and methods for treating or preventing infection by Toxin A producing bacteria.
    Type: Application
    Filed: May 11, 2009
    Publication date: November 12, 2009
    Applicant: RECOPHARMA AB
    Inventors: Jan Holgersson, Anki Gustafsson
  • Publication number: 20090280104
    Abstract: The present invention provides compositions and methods for treating or preventing infection by shiga toxin producing bacteria.
    Type: Application
    Filed: May 11, 2009
    Publication date: November 12, 2009
    Applicant: RECOPHARMA AB
    Inventors: Jan Holgersson, Anki Gustafsson